Ting Yuan: Metabolic Factors Influencing IVF Success Beyond PCOS
Ting Yuan, Co-Founder and Clinical Director at Zhaoxi Fertility Center Malaysia, shared a post by Antonio Pellicer, Presidente en IVI RMA Global, on LinkedIn about a paper by Antonio Pellicer et al published in Human Reproduction:
“Most people think fertility is about the embryo.
But that’s often not the real problem.
Fertility is not just about one organ.
It’s a system.
A recent study suggests something we may be underestimating in clinical practice:
- Insulin resistance is not limited to PCOS
- It can significantly affect outcomes even in non-PCOS patients
I often explain fertility using a simple framework:
- Seed → embryo quality
- Soil → endometrial receptivity
- Sunlight → hormonal regulation
- Water → metabolic health (especially insulin sensitivity)
In reality, we tend to focus heavily on the ‘seed’ and the ‘soil’.
But if the ‘water system’ is disrupted, the entire ecosystem is affected.
Even a high-quality embryo may fail in an imbalanced internal environment.
In my experience, some of the most challenging IVF cases are not about embryo quality – but about underlying metabolic imbalance.
This is why fertility care may need a shift:
- from organ-focused thinking
- to system-level, integrative management
Curious do you routinely assess metabolic factors beyond PCOS in your patient?”
Quoting Antonio Pellicer’s post:
“A multicenter retrospective cohort study from the IVIRMA Global Research Alliance reported that 30.5% of non-PCOS infertile women presented insulin resistance.
In this population, insulin resistance was observed to be associated with higher clinical miscarriage rates and lower live birth rates compared to insulin-sensitive patients.
Among insulin-resistant patients, metformin exposure prior to embryo transfer was observed to be associated with higher clinical pregnancy rates, lower miscarriage rates, and increased live birth rates.
These findings should be interpreted with caution in light of the retrospective study design and potential confounding factors, and do not imply direct clinical recommendations.
They may support the hypothesis that metabolic factors could be considered as part of a broader clinical assessment, beyond traditional diagnostic categories.
Further prospective studies are required to confirm these observations and to better define their clinical implications.
Title: Association of insulin resistance with in vitro fertilization outcomes in women without polycystic ovarian syndrome: potential improvement with metformin treatment
Authors: Ana Belén Albert, Ana Corachán, Elena Juárez-Barber, Mauro Cozzolino, Antonio Pellicer, Diana Alecsandru, Irene Cervelló, Hortensia Ferrero

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 15, 2026, 12:21Zara Grigoryan: Open Expert Dialogue to Shape Women’s Health in Armenia
-
Jun 15, 2026, 12:12Abhishek Saxena։ Can a 5PN Embryo Develop Normally?
-
Jun 15, 2026, 12:02Does Growth Hormone Help in IVF? – Fertility Plus
-
Jun 15, 2026, 11:55Allen Morgan: PRP in Fertility Treatment, Emerging Evidence and Future Directions
-
Jun 15, 2026, 11:49Hereditary Gynecologic Cancer Care Is Evolving, but Access and Health Systems Remain Unequal – IJGO
-
Jun 15, 2026, 11:41Celebrating Community and Support at the Annual Fertili’Tea Party! – CFAS
-
Jun 15, 2026, 11:37Christopher Robinson: Outcomes in Late Preterm and Term Births with Gestational Diabetes vs Normoglycemia
-
Jun 15, 2026, 11:34Registration Now Open for Fertility 2027 – British Fertility Society
-
Jun 15, 2026, 11:28Ioakeim Sapantzoglou: Excited to Share Our Latest Publication in Archives of Gynecology and Obstetrics!
